Genomics data management and analysis platform DNAStack has secured a follow-on investment from Facit, building on the commercialisation unit's initial commitment in 2017.

Canada-based genomics data management business DNAStack attracted an undisclosed sum yesterday from Fight Against Cancer Innovation Trust (Facit), a commercialisation operation backed by Ontario Institute for Cancer Research.
The cash came through Facit’s Compass Rose Oncology Fund, an investment vehicle that mainly backs Ontario-based technologies with the potential to benefit patients with cancer.
Founded in 2014, DNAStack has created a cloud-based data storage, bioinformatics and sharing platform for genomics projects that allows researchers to upload, process and interpret large amounts…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?